Cell and gene therapies (CGTs) have long been heralded for their potential to revolutionize the treatment of complex and previously…
Read More

Cell and gene therapies (CGTs) have long been heralded for their potential to revolutionize the treatment of complex and previously…
Read More
Madrigal Pharmaceuticals has significantly bolstered its pipeline for metabolic dysfunction-associated steatohepatitis (MASH) by acquiring the global rights to Arrowhead Pharmaceuticals’…
Read More
In a significant advancement for hematological oncology, researchers from Ludwig Cancer Research have identified a promising new therapeutic strategy to…
Read More
In a landmark move poised to redefine the landscape of dermatological therapeutics, LEO Pharma, a global leader in medical dermatology,…
Read More
The RESILIENCE Skills program, a comprehensive UK-wide initiative, is actively addressing a critical talent deficit in advanced medicines manufacturing, a…
Read More
The landscape of cancer care is undergoing a profound transformation, marked by significant advancements in diagnostics and therapeutics that have…
Read More
Regeneron Pharmaceuticals has entered into a significant drug pricing agreement with the White House, marking a pivotal moment in the…
Read More
Acute myelogenous leukemia (AML) remains one of the most formidable challenges in modern oncology, characterized by a rapid progression and…
Read More
A groundbreaking international study, spearheaded by researchers from the University of Ottawa Faculty of Medicine in Canada, has introduced a…
Read More
In a significant advancement for neurobiology and pain management, researchers from the University of Pennsylvania, Stanford University, and Carnegie Mellon…
Read More